AHK-Cu is a synthetic copper-carrying peptide, applied mostly as a scalp serum and increasingly injected, by people hoping to keep hair, improve skin and support tissue repair. It is untested in people; support comes from human hair follicles kept alive outside the body and animal studies. Main risks: excess copper, contaminated research-use vials, skin irritation. A low-cost, plausible but unproven hair and skin experiment, most uncertain when injected. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum copper | 70–140 µg/dL | Rising values signal copper excess |
| Ceruloplasmin | 20–40 mg/dL | Low values suggest Wilson disease |
| ALT | 7–56 U/L | Liver safety; elevation stops or changes use |
| Hair count/density (phototrichogram) | No established target; track change from own baseline | Expected to change if AHK-Cu works |
Cadence: Injected use: laboratory tests at baseline, 8–12 weeks, then every 6 months while use continues; topical use: repeat laboratory tests only if total copper intake is high. Hair photographs and counts at baseline, 3 and 6 months.